Circulating Biomarker for Liquid Biopsy Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Circulating Tumor Cells (CTCs)
1.2.3 Circulating Tumor DNA (ctDNA)
1.2.4 Cell-Free DNA (cfDNA)
1.2.5 Extracellular Vesicles (EVs)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Early Cancer Screening
1.3.3 Therapy Selection
1.3.4 Treatment Monitoring
1.3.5 Recurrence Monitoring Orthopedics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circulating Biomarker for Liquid Biopsy Market Perspective (2017-2028)
2.2 Circulating Biomarker for Liquid Biopsy Growth Trends by Region
2.2.1 Circulating Biomarker for Liquid Biopsy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Circulating Biomarker for Liquid Biopsy Historic Market Size by Region (2017-2022)
2.2.3 Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2023-2028)
2.3 Circulating Biomarker for Liquid Biopsy Market Dynamics
2.3.1 Circulating Biomarker for Liquid Biopsy Industry Trends
2.3.2 Circulating Biomarker for Liquid Biopsy Market Drivers
2.3.3 Circulating Biomarker for Liquid Biopsy Market Challenges
2.3.4 Circulating Biomarker for Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue
3.1.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue (2017-2022)
3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2017-2022)
3.2 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Biomarker for Liquid Biopsy Revenue
3.4 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio
3.4.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2021
3.5 Circulating Biomarker for Liquid Biopsy Key Players Head office and Area Served
3.6 Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Circulating Biomarker for Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Biomarker for Liquid Biopsy Breakdown Data by Type
4.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Type (2017-2022)
4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2023-2028)
5 Circulating Biomarker for Liquid Biopsy Breakdown Data by Application
5.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Application (2017-2022)
5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
6.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
6.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
7.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
8.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
8.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
9.2 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
9.3 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
10.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
10.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
11.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Detail
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
11.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
11.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.3.5 GE Healthcare Recent Development
11.4 Epigenomics AG
11.4.1 Epigenomics AG Company Detail
11.4.2 Epigenomics AG Business Overview
11.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
11.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.4.5 Epigenomics AG Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
11.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.5.5 Agilent Technologies Recent Development
11.6 Biocept
11.6.1 Biocept Company Detail
11.6.2 Biocept Business Overview
11.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
11.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.6.5 Biocept Recent Development
11.7 Affymetrix
11.7.1 Affymetrix Company Detail
11.7.2 Affymetrix Business Overview
11.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
11.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.7.5 Affymetrix Recent Development
11.8 Fluxion Biosciences
11.8.1 Fluxion Biosciences Company Detail
11.8.2 Fluxion Biosciences Business Overview
11.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
11.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.8.5 Fluxion Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Circulating Tumor Cells (CTCs)
Table 3. Key Players of Circulating Tumor DNA (ctDNA)
Table 4. Key Players of Cell-Free DNA (cfDNA)
Table 5. Key Players of Extracellular Vesicles (EVs)
Table 6. Key Players of Others
Table 7. Global Circulating Biomarker for Liquid Biopsy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2017-2022)
Table 11. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2023-2028)
Table 13. Circulating Biomarker for Liquid Biopsy Market Trends
Table 14. Circulating Biomarker for Liquid Biopsy Market Drivers
Table 15. Circulating Biomarker for Liquid Biopsy Market Challenges
Table 16. Circulating Biomarker for Liquid Biopsy Market Restraints
Table 17. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Circulating Biomarker for Liquid Biopsy Market Share by Players (2017-2022)
Table 19. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2021)
Table 20. Ranking of Global Top Circulating Biomarker for Liquid Biopsy Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
Table 24. Date of Enter into Circulating Biomarker for Liquid Biopsy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2017-2022)
Table 28. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2023-2028)
Table 30. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2017-2022)
Table 32. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2023-2028)
Table 34. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 44. Abbott Laboratories Company Detail
Table 45. Abbott Laboratories Business Overview
Table 46. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product
Table 47. Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 48. Abbott Laboratories Recent Development
Table 49. Becton, Dickinson and Company Company Detail
Table 50. Becton, Dickinson and Company Business Overview
Table 51. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product
Table 52. Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 53. Becton, Dickinson and Company Recent Development
Table 54. GE Healthcare Company Detail
Table 55. GE Healthcare Business Overview
Table 56. GE Healthcare Circulating Biomarker for Liquid Biopsy Product
Table 57. GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 58. GE Healthcare Recent Development
Table 59. Epigenomics AG Company Detail
Table 60. Epigenomics AG Business Overview
Table 61. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product
Table 62. Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 63. Epigenomics AG Recent Development
Table 64. Agilent Technologies Company Detail
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product
Table 67. Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 68. Agilent Technologies Recent Development
Table 69. Biocept Company Detail
Table 70. Biocept Business Overview
Table 71. Biocept Circulating Biomarker for Liquid Biopsy Product
Table 72. Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 73. Biocept Recent Development
Table 74. Affymetrix Company Detail
Table 75. Affymetrix Business Overview
Table 76. Affymetrix Circulating Biomarker for Liquid Biopsy Product
Table 77. Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 78. Affymetrix Recent Development
Table 79. Fluxion Biosciences Company Detail
Table 80. Fluxion Biosciences Business Overview
Table 81. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product
Table 82. Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 83. Fluxion Biosciences Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Biomarker for Liquid Biopsy Market Share by Type: 2021 VS 2028
Figure 2. Circulating Tumor Cells (CTCs) Features
Figure 3. Circulating Tumor DNA (ctDNA) Features
Figure 4. Cell-Free DNA (cfDNA) Features
Figure 5. Extracellular Vesicles (EVs) Features
Figure 6. Others Features
Figure 7. Global Circulating Biomarker for Liquid Biopsy Market Share by Application in 2021 & 2028
Figure 8. Early Cancer Screening Case Studies
Figure 9. Therapy Selection Case Studies
Figure 10. Treatment Monitoring Case Studies
Figure 11. Recurrence Monitoring Orthopedics Case Studies
Figure 12. Circulating Biomarker for Liquid Biopsy Report Years Considered
Figure 13. Global Circulating Biomarker for Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Circulating Biomarker for Liquid Biopsy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Circulating Biomarker for Liquid Biopsy Market Share by Region: 2021 VS 2028
Figure 16. Global Circulating Biomarker for Liquid Biopsy Market Share by Players in 2021
Figure 17. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2021
Figure 19. North America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Circulating Biomarker for Liquid Biopsy Market Share by Country (2017-2028)
Figure 21. United States Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Circulating Biomarker for Liquid Biopsy Market Share by Country (2017-2028)
Figure 25. Germany Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Region (2017-2028)
Figure 33. China Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Circulating Biomarker for Liquid Biopsy Market Share by Country (2017-2028)
Figure 41. Mexico Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Country (2017-2028)
Figure 45. Turkey Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 48. Becton, Dickinson and Company Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 49. GE Healthcare Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 50. Epigenomics AG Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 51. Agilent Technologies Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 52. Biocept Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 53. Affymetrix Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 54. Fluxion Biosciences Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Industry Market Size
